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Long-Term Clinical Outcome After Stent Implantation in Saphenous 
Vein Grafts 
seven patlerits (11%) sbaiwi a oajor card@ event: two deaths 
(3%), two myocardiol iofkctious (3%) and three aqent bypass 
surgeries (5%). The clinical sucww rate+ tbem& was 89%. 
During the fbliow-up period (n&an 2.5 years, rafige B b 5;)), 
another tip palients (II%) died, I4 (23?6) sustabted a q yocanLJ 
iafarctioo, 12 (20%) underweat bypass surgery, and I4 (23%) 
undenveot angioplasty. ‘fbe estimated S-year survival aml event- 
angioplasty) wore (mean * SD) S3 f Sk &%J co&&e in&al 
[cl] 73% to q%) ad 38 -c 7% (95% CI 16% to 44%). respectively. 
C~QCIUS~~IU. The ln-hospital outcome of potknts who nnder- 
went stent implantatioa in a vein graft is acceptable, but tbe 
long-term clinical outcome is poor. It is uu”kely that me&a&al 
intervention alone will provide a satisfactory or deli&e answer 
for the patient with graR s&rosis over the ioag term. 
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O&&es. We sought to determine the role of stoat implenta- 
tion in vein grafts by evaluating the long-term cliniwl outcome 
and estimated event-free survival at 5 years in 62 patients and by 
comparing our data with tbose of other treatment modalities 
previously reported. 
Buckgfwund Patients with recurrent angina after eoroaaiy 
artery bypass graft surgery pose a prublem. Stent implantation 
has bezn advocated in an effort to avoid repeat operation and to 
address the limitations of balloon angioplasty. 
kf&wn!v. Patients undergoing stenting of a vein graft were 
entered into a dediited data base. They were screened for death, 
infarction, bypass surgery and regeat angioplasty. Prucedure- 
related events were included in the follow-up analysis. Survival 
and event-free survival curves were constructed by the Kaplan- 
Meier method. 
Resak A total of 93 stents (S4 Wallstent and 9 Palmas-Schatz) 
were implanted in 62 patients. During the in-hospital period, 
Coronary artery bypass graft surgery effectively relieve? an$na 
in patirtlta wilh obstructive coronary artcry discax and may 
prolong life in a selected group of patients (1,2). Recurrence of 
angina, however, occurs in 5% to 10% of patients each year 
and is mainly due to graft failure or a combination of graft 
failure and progression of coronary atherosclerosis (3-5). 
Serial angiographic studies revealed that 15% to 30% of the 
grafts are stenosed at 1 year after surgery and that nearly 50% 
of the grafts are closed at 10 years after surgery (6-g). 
As the number of patients who undergo surgery increases, 
the number of patients with recurrent angina due to graft 
failure will also increase (9,1(i). Optimal management of these 
patients remains a subject of debate. In addition to pharma- 
culogic treatment. othl’r therapeutic options are repeat surgery 
or percutaneous re\aa;ularization. In general, repeat surgery is 
associated wit? an increased morbidity and mortality and less 
symptomatic relief in comparison to a first operation (10-12). 
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Balloon anpioplasty of vein grafts may sxcessfully be per- 
formed in selected patients but is plagued by a high restenosis 
rate (3). Patients with old, diffusely diseased or totaEly occluded 
grafts are at an increase* risk of major cardiac complications 
owing to the risk of emboiization of friable graft tissue into the 
coronary circulation (3). As a result, the use of stents is 
advocated to treat such patients. This is not only based on the 
fact that steqts can be easily implanted in large vessels and may 
contain friable graft tissue and thus reduce the risk of embo- 
lization, but also on the assumption that the superior angio- 
graphic outcome immediately after implantation will be trans- 
lated into a superior long-term clinical outcome (13,14). 
Clinical benefit, however. is largely based on anecdotal expe- 
rience and a number of case studies with special emphasis on 
technical success rates and short-term rather than long-term 
clinical outcome. Randomized clinical trials are now under way 
to address this issue (15). They may, however, fail to give a 
definite answer olving ‘to stringent inclusion and exclusion 
criteria. To reinforcc: the debate on the role of stent implan- 
tation in vein grafts and while awaiting the results df random- 
ized trials, we repori the immediate and lony-term clinical 
outcome ‘q a series of 62 patients who underwent stent 
implantation in a rein graft. All patients gave written informed 
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Tat& I. Baseline Clinical and Angiographic C~harilcterislin of 6? 
Study Patients -I_- ---____ 
Median alle (vrl 65 
43-1X 
52 (W.) 
37 (60%) 
17 (27%) 
Rant’_ . 
Men 
Previous AMI 
Previous PICA 
Risk facum 
Smoking 
ttypercholesterolemia 
Hypertension 
Dl&IL3 
NYHA fimctionai class 
;I 
III 
IV 
Veswl disease 
12 (194/o) 
32 (52%) 
17(27%) 
7(11r’) 
2 (35) 
7(11%) 
3l(so~;) 
22 (3h:i.) 
I (29) 
12(14%) 
4’) (7Y’B) 
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constitute 1.2% of the 5.340 patient\ who underwent coronary 
angioplasty in our institution.during the same period. Baseline 
clinical and angiographic characteristics are shown in Table 1. 
The majority of patients underwent stcnt implantation because 
of severe angina pectoris (New York Heart Association 
[NYHA] classes III and IV, 86%) and as a treatment for a de 
novo graft lesion (82%). Most of the grafts were old (median 
age 7.7 years) and were, in general. diffusely diseased, as shown 
in Figure 1, Dutailed baseline angiographic data were available 
in 57 patients and are shown in Table 2. 
Stent implantation. Stent implantation was performed by 
standard techniques using the femoral approach. as previously 
described (16). The target lesion was first dilated with a 
balloon catheter to facilitate stent delivery. At variance with 
current standards of stent implantation, additional balloon 
dilation after stenting was performed in only 44 patients 
(71%). This was done with semicompliant balloons equal in 
size to or 0.5 mm lmger than the interpolated reference 
diameter of the bypass graft (on-line quantitative coronary 
angiographic measurement) and by using pressures ranging 
from 10 to 14 atm. The total number, type and size of stcnts 
implanted are shown in Table 2. In almost all patients (90%) a 
Wallstent was used. 
The postoperative treatment changed throllghout the study 
period. While all patients were treated with a combination of 
acetylsalicylic acid, dipyridamole, heparin and acenocoumarol 
immediately after implantation, the first 26 patients also 
received 100,000 to 250,000 IJ of intravenous urokinase, which 
waq infused through the guiding catheter into the vein graft. 
Thmmbolytic therapy was later withheld from the postopera- 
tive treatment because of a high frequency of major bleeding 
complications, particularly at the vascular access Gte. 
Stent implantal:ion was regarded to be angiographically 
srlccessful when there was no r&&l stenosis within the 
stented segment by visual assessmeni. A clinically successful 
stent implantation was defined as an angiographically succcss- 
ful implantation free of procedure-related complications lead- 
ing to death, myocardial infarction, bypass surgery or repeat 
consent before stent implantation, and the study was approved 
by the Xxlical Ethical Coibimittcc of our institutiot. 
Methods 
‘Patients. Between November IY86 and June 1994, 62 
@CT.!:: llndenvent stent implantation in a vein graft. They 
Figure 1. Angbugraphic result immediately aftcc implanta- 
tion of three Palmaz&hatz stcnts il l a graft supplying the 
left anterior descending coronary artety. 
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Table 2. Stem Implantation and Quantitative and Qualitative 
Angiographic Data 
dent data 
‘?iml no. of rtents 93(IM)Yv) 
No. of stentsipatient 1.5 
Wallstent Ii4 (PO%) 
Palmaz-Wait2 stent 9(109) 
Nominal size 
3.0 5 (sa) 
3.5 25 (274) 
4.0 .3X(41%) 
4.5 14(l5%) 
5.11 X(7Pi) 
5.5 I(i’t) 
6.0 2 (2%) 
Quantitative angiojgraphic data (57 p’s) 
Reference diameter (mm) 
Before stenting 3.3 2 I.8 
After stcnting 3.5 t 2, 
Mimmal lumen diameter (mm, 
Before stentmg 1.4 2 05 
Afltx stentmg 2.7 + 3.1 
Diameter swwsis (%) 
Edore stenting 58 t 2.0 
After stenting ZYZY 
Lesion IengG~ :mm) 
Before stenting 16.5 -’ ft.3 
After stenting - 
Oualilative an&graphic data (62 pts) 
Chronically occluded grafts 0 (0) 
Presence of thrombus 3(W) 
Long lesions (> 15 mm) 32 (52%) 
Tandem lesions 23 (37?) 
lesion containing ulcus 25 (WV, 
- 
Data prescntcd arc mean value 2 SD or numt,dr (ci) of patient, (pts). 
angioplasty. A periprocedural infarction was determined by 
the development of new Q waves or au increase in the serum 
cardiac enzymes to more than twice the upper timit of normal. 
Data collection and follow-up. Procedural details. includ- 
ing complications, were prospectively entered into a dedicated 
data base at the time of implantation. Procedure-related 
events were included in the follow-up analyses. All patients 
who survived their hospital stay were checked against the civil 
registry to establish survival or death. Patients were screened 
for the occurrence of death, acute myocardial infarction, 
recurrent angina necessitating repeat percutaneous revascuiar- 
ization or repeat bypass surgery. Clinical follow-up informa- 
tion was obtained retrospectively through an interview during 
outpatient clinic visits or from the patient or family by teb- 
phone or from the referring physician. Two patients were lost 
to follow-up. As a result, follow-up was complete for 60 
patients (98%). The median period of follow-up was 2.5 years 
(range 0 to 5.9). Patient survival cutves and event-free plots 
were constructed by the Kaplan-Meier method. Repeat an- 
giography 6 months after stent implantation was performed in 
only 43 patients (69%). 
Results 
lo-bospital outcome. A total of 93 stents were implanted 
(Table 2). In one patient, stent implantation was unsuccessful. 
Therefore, the implantation or angiographic success raze was 
98%. In seven patients, 3 total of uine major cardiac events 
occurred during the hospital period (Table 3). As a result, the 
ov~~-~:ll clinical success rate was 89%. Two patients (3.2%) died 
after ~stent implantation. Both of them received thrombolytic 
therapy-one patient because of protocol requirements during 
the initial study period and the ather patient because af an 
acute myocardial infarction that was treated with balloon 
angioplasty and subsequent stent implantation, in addition to 
thrombolysis. In this patient, emholization of the graft material 
was noted during the procedure, which resulted in a creatine 
kinase (CK) elevation to 640 U/liter. A computed tomographic 
scan confirmed intracranial hemorrhage in both patients. TWO 
other patients (3.2%) developed an acute myocardial infarc- 
tion during their hospital stay, with a CK elevation to 706 and 
1,100 IWiter. One of these two patients was admitted because 
of an acute inferior infarction and was treated with balloon 
angiop!Pc?, and stent implantation into the graft supplying the 
right coronary artery. The other patient developed an antero- 
lateral infarction with a CK elevation to 706 W/liter 4 days 
afte; stent implantation. Although the infarction was mainly 
caused by a subacute stent thrombosis, the exact cause was not 
documented. Another three patients (4.8%) were referred for 
Table 3. Major Cardiac Events During tiospital Stay and Atier Discharge 
--- - 
IvHowital (n = 62) After Discharge (a - HI)’ Total (fl = 62) 
-- -- 
x)ti,i Rankmg Tolal Rang Total Ranking 
.- - --- 
I‘wn 
Death 2 1.3’;) 2(3’i) 5 (X“:) 5 (II’; I 7tII’i8) 7( II’;,) 
AMI 3 {S’h) ? (3';) I4 (23’;) I4 (23’;) I7 (27’S) I6 (XI’? ) 
CAmG 3 (SC,.) 3 (SC,) I? (at?) I2 (XL;) IS (24’;‘) I5 (2Vi) 
Re-PTCA I (Yh) 0 IX (.Ul?) I4 (23G) 19 (3lPi) 1-l (23Y) 
Total 9, W2) 
-~___ 
7(119) 49 (XX) 45 (75%) 58 (94%) 52 (84%) 
*Two ptienls 1~1 (I) folhwup. Data presemed are number (76) of patirnls. Rankiag = frequency of cwnls in 
descending order of ir-erity (death [wrst owumcl. folkwcd m order of rank. by acute myocardial infarct& [AMI], 
bypass surgery ICABGJ. repeat intervention [Re-PTCAI). Total = told count 01 all rvenb (Iw~nmuttutly wlusivc 
analy+. 
free from mvocardial infarction at 5 vears was 61 C 6% (95% 
I  
Cl 49% to 73%) and event-fret ;&ival at 5 years free from 
myocardial infarction, bypass surgery and angioplasty was 30 i: 
7%: (95%’ Cl 16% to 44%). 
Discussion 
years 
Figare 2. Survival and event-free survival curves (Kaplan-Meierj of 
patients who underwent stent implantation in a vein gmft. CABG = 
coronary artery bypass graft strrgery: Ml = mywardial infarction; 
REPTCA = repeat percutaneous transluminal coronary angioplasty. 
The present study describes the immediate and long-term 
clinical outcome of 62 patients with angina pectoris %.ho 
underwent stent implantation in a vein graft. The angiogaphic 
indication was a de novo lesion in the majority of patients 
(82t”-) klld a restenotic lesion in 13%. Taking into account the 
limitatrons of this study-on the one hand, the design and 
therefore the potential shortcomings in the accuracy of data 
collection, and on the other hand, the fact that it concerns a 
series of nonconsec&ve patients with, in general, advanced 
urgent bypass surgery; one patient because of recurrent angina graft failure-the main message of the present study is that 
I1 days after stent implantation and two other patients because stent implantation in vein grafts can be safely performed but 
of a documented subacute stent thrombosis. In one of these that the long-term clinical outcome is poor. This should be 
two patients, anticoagu!ation was stopped because of gastro- interpreted when taking into accou.lt that in the, majority of 
intestinal bleeding (Mallory-Weiss syndrome). patients a Wallstent was implanted and that high pressure 
In addition, a major bleeding complication necessitating balloon dilations according to current standards were not 
blood transfusion occurred in six patients (9.8%)~two groin performed. Changes in stent design and, especially, implanta- 
(3.20/o), three gastrointestinal (4.8%), one retroperitoneal tion and deployment technique may have beneficially influ- 
(I.h%)-and a vascular access site complication necessitating elced early and late outcomes (13,15). 
surgery or blood transfusion, or both, in another eight patients In-hospital results. With respect to safety, the frequency of 
(12.9%). The median hospital stay for the total study cohort in-hospital events is acceptable despite advancing graft age and 
was 9 days (range 5 to 53). the complications one could anticipate from such a graft based 
Clinical events after hospital discharge. Table 3 lists the on the underlying histopathologic substrate described by Sabre 
occurrence of major events after hospital discharge. There c: d!. (17). The reported frequency of in-hospital events 
were five deaths (8%~). two of which were cardiac, one noncar- compares favorably with that after balloon angioplasty of vein 
disc and two of unknown etiology. Fourteen patients (23%) graft lesions and with that after repeat bypass surgery (Tables 
sustained a nonfatal myocardial infarction. In 2 of these 14 4 and 5) (N-50). It is, however, inferior to the frequency after 
patients. myocardial infarction was associated with a repeat stent implantation in vein grafts reported by other investigators 
balloon angioplasty during the follow-up period. Twelve pa- (51-63) (Table 6). Again, OX should account for the type of 
tients (20%) underwent repeat bypass surgery at a median patients treated in this study. In most other reported studies 
interval of 7 months (range I to 43). In all but one of these shown in Table 6, 70% to 80% of the patients nad a discrete 
patients, the indication of repeat surgery was angina pectoris in lesion <IO to 13 mm long; thus, they may represent a more 
association with restenosis of the stented graft segment. Re- favorable group of patients. Furthermore, it should be recog- 
peat angioplasty was performed in 18 other patients (30%) at nized that two palients d;fd because of an intracranial hem- 
a medium interval of 6 months (range I to 32). As for the orrhage after thrombolytic therapy, and that two other patients 
patients who underwent repeat bypass surgery, in all but one, rcceivcd a stent in the setti:lg cf an acute myocardial infarc- 
the angiograpluc indication to perform anginplasty was resten- tion. Fine tuning of the Indication for stent implantation and of 
osis in or adjacent to the stentcd graft segment. Repeat the periprocedural and postprocedural pharmacologic treat- 
angioplasty was successful in 16 patients but was complicated ment by systemic use of high pressure balloon dilations may 
by a myocardial infarction in two. Repeat angiography 6 have resulted in a better immediate outcome. It is noteworthy 
months after stent implantation was performed in 43 patients that despite the above observations, the frequency of in- 
(ho’+) Rcstenosis (50% diameter stenosis criterion) was doc- hospital major cardiac events compares favorably with that 
umented in 23 patients (S3%), 7 of whom undcrwcnt repeat after stent implantation in coronary artcrics. The reported 
angiopla~ty and 6 bypass surgery. During the further follow-up, frequencies ‘of death, acute myocardial infarction and emer- 
another seven and six fUtiL!ntS underwent repeat angioplasty gency bypass suigery in 1,191 patients treated with a stent in a 
and bypass surgery, respectively. because of graft failure & the coronary artery betweeu l98Y and 1992~~~ 2.0,3.3 alli l.Y%, 
stented site in all but two patients. respectively (64). 
Survival and event-free survival. The mean lz SD esti- Long-term results, The long-term clinical outcome is dis- 
mated surviv.bl at 5 years after dent implantation was 83 r+l 5% turbing. This is not so much because of the estimated 5-year 
(95% confidence interval [Cl] 73% to 93%) (Fig. 2). Survival survival rates, which was 83% in this study. The long-term 
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Table 4. In-Hospital Events After Balloon Angioplasty of Saphenous Vein Grafts 
SlUdV 
FirSI 
Author YM 
Ref. Study No. of A&- Graft Age Death AMI CABG 
NO. Period Rs (Yr) W) rw (W w 
Ford 1981 
Jones 1983 
Douglas 1983 
El-Gamal 1984 
Block 1984 
Corbelli 1985 
Rceder 19R6 
Cole 19x7 
Ermt 19x; 
DorUJS 1988 
Reed 1989 
Platko 1989 
Webb 19% 
JOS! 199I 
Reeves 1991 
Plokker I991 
Meester LugI 
While 1993 
MOrriSOIl 1994 
Totai/weiabted average 
18 1978-1979 
19 1978-1982 
20 1978-1992 
?I 1980-1982 
22 1979-1982 
23 19X1-1984 
24 1979-1981 
2s I981-1985 
26 1980-1985 
21 1979-1986 
28 19X3-1986 
29 MI-1987 
30 1978-1988 
31 1978-1983 
32 1981-1987 
33 1980-1989 
34 1981-191 
35 NR 
36 19&-lYY3 
37 
62 
31 
44 
35 
19 
82 
33 
53 
54 
I01 
140 
41 
57 
454 
84 
21 
15 
51 
54 
54 
NR 
56 
51 
60 
60 
59 
58 
58 
60 
NR 
51 
SR 
60 
60 
65 
62 
0.3to4.7 0 0 0 
2 0 5 5 
<Ito> 0 0 2 
R.3104.1 0 5 0 
G.09 0 0 2 
.:0.5,0 i5 0 0 2 
3 5 5 10 
4 0 4 1 
NR 0 6 0 
7 4 1 1 
3 0 0 0 
.I 2 6 2 
NR 0 4 1 
3 0 0 0 
5 2 Y 2 
6 1 3 1 
5 4 8 2 
IO 0 0 0 
8 3 3 I 
1 6 2 
NR = not reported; Ref = reference; otbir abbreviations as in Tables 1 to 3. 
survival does not differ from the 5-year survival in patients who 25% of the patients sustained an acute myocardial infarction at 
underwent balloon angioplasty of a vein graft iesion or who a median of 6 months (range 1 to 21) after the index 
underwent repeat bypass surgery. which have been reported to procedure, and almost 50% of the patients underwent repeat 
vary between 70% and 89% and 76% and 94%, respectively revascularization by means of either repeat bypass surgery 
(65-67) (Table 7). Rather, it is mainly because of a high (22%) or repeat angioplasty (23%) at a median of 7 (range 1 
incidence of myocardial infarction and a very strong need for to 43) and 6 (range I to 32) months, respectively. In all these 
repeat revascularization during the follow-up period. Almost patients, apart from two, the indication for repeat revascular- 
Table 5. In-Hospital Events After Repeat Bypass Surgery 
Study 
First Ref. Study No. of Age Grafi Age Death AMI Rrlhuramlomy Other 
Author Year NO. PI&ii PlS (Yd tY0 (‘h, P) 0) w 
Norwood 1977 37 19711-1975 26 40 0.5 8 12 NK- NR 
Reul 197Y 38 196x-I978 16X 51 NR s ? 2 22 
Sha5 19x3 39 1969-1980 106 4Y NR 3 x NR 11 
Foster 1984 11 1976-1979 283 52 3 5 6 5 5 
Cameron 19xX 40 197lJ-1973 64 jn 8 5 NR NR NR 
BrCooWllZ 19xX 41 1’,7?-IVxh IN 56 x 12 s 7 3 
chaka IWH 42 19711-IYP3 1 IY 52 4 3 9 3 3 
Verkkala IYKV 43 19711-IYXH 71 54 4 IO NR NR NR 
Nab I YH’J 44 IYWI-I986 IS 51 3 4 NR NR NR 
Irwp IWI 45 I’W7-lYX7 2,soY 57 6 4 1 x 9 
Vcrhcul IWl 16 lY7V-lV.y7 XI 5x 5 x 4 6 7 
Galbut IYYl 47 I%?-I9xR n8 6: 9 7 K 6 ?I 
Akl lw: 48 IYlil-1YYo 115 54 OS 5 4 NR 7 
H0Ilofl iYY2 49 IYRI-IWO 172 59 2-l 1 0 2 NR 
NOyZZ 1w4 50 1987-!YY? 16 so I1 0 3 IS 13 
Totakeighlcd average 4,160 5 6 7 9 
_--~. - 
Other = total wm of repxted complications, such as ccrebrouscuiar accident\ pulmonary and rend1 Iallure. hleedmg ad wund mfeaion: other dhbreviatioas 
as in Tables I, 2 and 4. 
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Tnbte 6. In-Hospital Events After Stem Implantation in Saphenous Vein Grafts --____ 
study 
First Ref. SlUdY No. of Age c,r;dc Age No. of De;rth AM1 (‘AIG PTC‘A Bleeding/ 
Authur Ycrr NO. Pcrind PIS Or) (Y’b Slcnls (5) (‘;I _,____ (1; I (56) Vase (0) -~-- 
Urha Ix39 51 I’)%-11)xX 13 h3 5 ?I1 0 0 I! NR IS 
de Scheerder VI92 52 I988-1990 h9 63 7 l3h 4 7 h 3 33 
Smmpf I’)92 53 IY90-1991 26 66 9 34 0 4 0 4 19 
POlll~ralN2 I’)92 S 1988-1991 69 66 Y 81 0 IO II NR 7 
White 1993 55 NR I1 64 NR 16 0 n (I I3 0 
WCMlg 1WJ S6 lY90-lY?J2 589 h6 9 NR ? n.3 I NR I6 
Eeckhout IYQ4 Sl l9%-lY93 40 63 8 5x tJ 2 2 NR 14 
FWllml lYY4 5x IYYII-IWI I ‘JX hh x NR II,5 Il.5 (1.5 (I.5 26 
Nordrehaug I’AJ 5’) NR IY 64 NH NR II II 0 h Ih 
heane I994 64 WI-I993 20 h3 III 35 It II (I II 17 
Piana lY9.l hl IOXK-IY93 150 M 9 30 I II 0 n 27 
Hwha-Sing IYYi h? IYXY-IYY2 22 hh NR NR 5 II 0 0 -7 
WClflg I995 h3 l’JwLl’9l 2.71 hh x .SM I I Il.4 (I.4 I 
-rotal~+~ -ll’r CL 4 Jag” I,466 I I I I Ih 
Present StIi”y I’)“” i+JJ 62 hS x 93 s 5 5 I 23 
-- ---_ -. 
Var : ~awdcr complications: vther abhroiationt aa m Talks I to 4. 
ization was failure of the graft at the sile of the xtented 
segment. As mentioned above, the use of high pressure balloon 
dilation after stcnting may have resulted in a lower restenosis 
rate and, consequently, less riced for subsequent revasculariza- 
tinn. 
Yet, although half of the major cardiac events occurred 
within the first 6 mon!hs alter stent implantation, these data 
and the configuration of the Kaplan-Meier plots indicate a 
continuous and progressive clinical deterioration beyond this 
period. Given the limitations of comparing those data with 
other studies rcportcd to dam, the l- and 5-year survival rates 
do not differ between the various treatment modalities for 
recurrence of angina due to graft failure (Table 7). The .C.year 
event&cc survival, however. appears to be significantly mfe- 
rior after balloon angioplasty or stent implantation when 
compared with repeat surgery. This is largely based on the 
stronger need of repeat revascularization after catheter-based 
interventions. It is, huwevrr. important to point out that the 
decision to proceed with another revascularization is not only 
patient but also physician related. The threshold for perform- 
ing a third or fourth repeat bypass operation is obviously much 
higher than for another angioplasty. If repeat surgery and 
angioplasty are excluded from the survival analysis, the 5-year 
survival free from myocardial infarction is 61 z 6% (95% CI 
49% to 73%). Nevertheless, patients who have had previous 
bypass surgery represent a select and difficult-to-manage sub- 
group of patients with ischemic heart disease. This is illustrated 
by the work of Lytle et al. from The Cleveland Clinic Foun- 
dation (68). They found tha; patients who have had previous 
bypass surgery do less well in terms of survival and event-free 
sutvivai, irrespective of the presence or absence of graft 
stenoses, in comparison with patients with ohstruc!ivc coronary 
artery discasc but without a previous bypass operation. Fur- 
thermore, it needs to be emphasized that the prognosis of 
patients who have hsd previous bypass surgery is determined 
not only by the extent of coronary artery disease and the 
degree of graft failure but also by other clinical and anatomic 
factors such as age, coexisting disorders, ventricular function 
and type of conduit used. Furthermore, it is noteworthy that 
the Cholesterol Lowering Atherosclerosis Study, in which male 
patients who have had previous bypass surgery were random- 
ized into a placebo group and a group receiving lipid- 
modifying drugs, revealed a significantly lower rate of progres- 
sion and a significantly higher rate of regression in the active 
Table 7. Survival and Event.Free Survival After Balloon An$q~lasty, Repeat Surgery or Stem Implantation in Saphenous Vein Grafts ______ __---._____- - - -.-I 
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treatment group (3~~% vs. 61% and 16% vs. 2.4%, respectively) 
(69). Therefore, risk factor i&Cation may play a role in the 
improvement of the late outcome. 
utherowlerosis in coronary arteries and bypw grafts: ten years later. Am J 
Cardiol IY%S3:l~l2C-7C. 
Study limitations. A number of limitations have been 
briefly mentioned above. In addition to the design, the major 
drawback of the present study is that the patient group does 
not comprise a series of consecutive patients. Therefore, the 
possibility of an important selection bias cannot be neglected. 
In addition, we have basically reserved stent implantation for 
patients with advanced graft failure. This is not only because of 
our own philosophy with respect to the management of these 
patients but also because our center is a tertiary referral center. 
Forty-three percent of the patients are referred because of this 
top referral function. The small number of patients did not 
allow us to stratify patients into subgroups to explore which 
patient may benefit more from this treatment than the other. 
Therefore, we are unable to give guidelines with respect to 
improvement in patient selection and indications. In addition, 
!he results reported herein need to be challenged by other 
investigators with larger series and, if pclssible, consecutive 
patients. Learning curve, more strict indications, improve- 
ments in stent design, changes in periprocedural procedures 
such as in-stent high pressure balloon dilations, which affect 
not only the postprocedural pharmacologic treatment but also 
potentially the clinical outcome, and, finally, more attention to 
risk factor modifications may contribute to superior results. 
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13. Leon MB. Wang SC, Piiard AD. Balloon-expandable stem implantation in 
saphenws vein grafts. In: Hermamt K. Hirshfield J. editors. Clinbi Use of 
the Palmaz-Schatz Inlracwortary Stem. Armonk (NY): Fu;ttra: (9%,3:111-21. 
I-?. Strauss BH, Serrur FW, Bertrand ME, et al. Quattt~~a~ive ttngiographiu 
folkwup of coronary Wallstent in native vewh and bypass grafts. Am J 
Cardiil 1992:69:47.5-81. 
15. Savage M. Douglas J, Fisehman D. et al. Coronaty stents versus balloon 
angioplasty for aortoeoronary sapbenous vein graft disease: interim nxdts 
of a randomized trial [abstract]. J Am Cull C&ii 1995;25:79A. 
16. Serruys PW, Strauss BH, Beatt KJ. et al. Angiographi follow-up after 
placement of a self+xpandingcorottary stew N Et@ J Med 1991;324:1>7. 
17. Saber RS, Edwards WD. Holmes DR. Vlietstra RE, Reeder OS. Balloon 
angioplacl~ of aortoaxonaty saphenous vein bypass grafts a hiiopatbologie 
studyofsixgr~ftsfrom fivepatientswithemphasisonrstenosbandembdie 
compiicatioe\’ J .%I Coil Cardiol 1988;12:1501-9. 
IS. Ford WB, Wholey MH, Ziib EA, Somadani SR, Sullivan MA. Petwtane~ 
ous trattsluminal c:ilat.,.Jon of aortocoronaty saphenous vein bypass grafts 
Chest 19xl;ij:5,!!-35. Conclusions. The management of patients with recurrent 
angina and graft failure is complex. In this historical series of 
nonconsecutive patients. in which the self-expanding Wallstent 
was predominantly used according to previous standards of 
stenting, stent implantation was associated with a poor long- 
term clinical outcome. These observations needs IO be chal- 
lenged by more recent studies. It may well be that changes in 
stent design and the systematic use of in-stent high pressure 
balloon dilations may result in a better long-term outcome. In 
addition, attention needs to bc paid to risk factor modification 
to reduce long-term graft failure. 
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